Prudential Financial Inc Tarsus Pharmaceuticals, Inc. Transaction History
Prudential Financial Inc
- $74.4 Billion
- Q2 2025
A detailed history of Prudential Financial Inc transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 182,400 shares of TARS stock, worth $13.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
182,400
Previous 120,805
50.99%
Holding current value
$13.5 Million
Previous $6.21 Million
19.08%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TARS
# of Institutions
226Shares Held
46.9MCall Options Held
20.5KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$242 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$230 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$220 Million5.63% of portfolio
-
Jennison Associates LLC2.6MShares$193 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$182 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.97B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...